Medical/Pharmaceuticals

Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion

QINGDAO, China, May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in global life science laboratory equipment sales and No. 1 in overseas sales in the same category, according to 2025 data published by Euromonitor I...

2026-05-28 21:25 10495

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell therapy, have been selected for an oral presentation a...

2026-05-28 19:00 4022

REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

FERNANDINA BEACH, Fla., May 28, 2026 /PRNewswire/ -- Ponce De Leon Health (PDLH), a commercial stage longevity company focused on the extension of healthspan and the reduction of biologic age in humans and animals, today highlighted the publication of alandmark peer-reviewed study in the scientif...

2026-05-28 18:38 4551

DA NANG GLOBAL BUSINESS SUMMIT 2026 - SILVER GENERATION INNOVATION EDITION

POSITIONING DA NANG AS SOUTHEAST ASIA'S INTERNATIONAL HUB FOR THE SILVER ECONOMY & MEDICAL TOURISM DA NANG, Vietnam, May 28, 2026 /PRNewswire/ -- The 3rd Da Nang Global Business Summit 2026, themed"Silver Generation Innovation", concluded successfully on May 15 at Pullman Danang Beach Resort, br...

2026-05-28 17:48 5311

Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific

New collaboration combines Philips' global imaging expertise with ASCI's clinical leadership and regional network to strengthen education and clinical excellence across the region SINGAPORE, May 28, 2026 /PRNewswire/ -- Royal Philips  (NYSE: PHG, AEX: PHIA), a ...

2026-05-28 17:34 13466

Scientific forum in Singapore explores advanced PET/CT imaging

SINGAPORE, May 28, 2026 /PRNewswire/ -- Singapore General Hospital (SGH), a leading academic medical centre in Singapore, on May 21 hosted "Advancing Precision Imaging with Next Generation PET/CT," a scientific forum that brought together experts in molecular imaging, nuclear medicine, radiology,...

2026-05-28 14:16 6634

Dymax Expands HLC Adhesive Portfolio with New Low Viscosity Medical Product

--New Adhesive Enables Reliable Bonding in Both Light and Shadowed Areas SINGAPORE, May 28, 2026 /PRNewswire/ -- Dymax, a global manufacturer of light-curing materials and equipment, today announced the release ofHLC-M-1004

2026-05-28 11:45 4897

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 28, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...

2026-05-28 11:10 4085

Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease

SUZHOU, China and MÖLNDAL, Sweden, May 28, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (stock code 06938.HK) and Ribocure Pharmaceuticals (together "Ribo") announce the submission of Phase 2 Clinical Trial Application (CTA) to the European Medicines Agency (EMA) for RBD1119, a siRNA based thera...

2026-05-28 10:43 5235

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 28, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...

2026-05-28 10:37 5947

Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer

SHANGHAI and HONG KONG, May 28, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-05-28 08:00 5482

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test

SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions , a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has grantedBreakthrough Device Design...

2026-05-28 06:00 5926

Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help

Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines for cancer prevention, screening, treatment, and supportive care. PLYMOUTH MEETING, Pa., May 27, 2026 /PRNewswire/ -- The National Comprehensive C...

2026-05-27 21:47 4751

Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit

Democratizing metabolomics for researchers worldwide, the new kit brings Metabolon's analytically rigorous, scalable metabolomics into workflows designed for integrated biological insights MORRISVILLE, N.C., May 27, 2026 /PRNewswire/ -- Metabolon

2026-05-27 20:45 5195

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...

2026-05-27 20:00 6857

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

- Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone - Data from Cohort 4 suggested that participants responding to prior BRII‑179 treatment achieved the most robust fun...

2026-05-27 19:00 7379

Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List

HONG KONG, May 27, 2026 /PRNewswire/ -- On 27 May 2026, Fortune China magazine released its 2026 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the Industry Star List. This highlights...

2026-05-27 17:43 8863

CGBIO Signs Global Clinical and Exclusive Commercialization Agreement for NOVOSIS in the U.S., Canada and Australia

* DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pathways * Full-scale entry into North America, the world's largest bone graft substi...

2026-05-27 14:00 6105

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs * CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North Augusta, South Carolina (USA) and Shanghai (China...

2026-05-27 13:00 6300

Doceree, Healthcare Marketing's AI-Powered Operating System, Earns Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition

Doceree is recognized as the AI leader in healthcare marketing for unifying the full prescription journey — from physician awareness to fill — on a single, clinically intelligent operating system. SAN ANTONIO, May 26, 2026 /PRNewswire/ -- Frost & Sullivan

2026-05-26 21:30 6240
1 ... 19202122232425 ... 382